E

    eXoZymes, Inc. (EXOZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.22
    +0.05 (+0.73%)

    Market Cap: $66.53M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.33N/AN/ABeat-17.9%
    Mar 26
    		$-0.28N/AN/ABeat-27.4%
    Dec 25
    		$-0.32N/AN/ABeat-31.8%
    Sep 25
    		$-0.27N/AN/ABeat-
    Jun 25
    		$-0.28N/AN/ABeat-
    Mar 25
    		$-0.22N/AN/ABeat-
    Dec 24
    		$-0.24N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-6.03EV/EBITDAN/A
    Price/FCF-8.76xFCF Yield-11.42%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-187.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio3.81xQuick Ratio3.81x
    Trading Statistics
    BetaN/AAvg Volume5.08K
    52-Week High$18.4052-Week Low$4.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.05
    SMA 20$6.27
    SMA 50$6.39
    SMA 200$9.48
    EMA 10$6.96
    EMA 20$6.56
    EMA 50$6.67
    EMA 200$8.91

    MACD

    Line: 0.38Signal: 0.22Hist: 0.17

    ADX

    ADX: 39.6+DI: 28.7-DI: 10.8

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down8.0
    PSAR$7.96

    Bollinger Bands

    Upper Band$8.08
    Lower Band$4.46
    %B Position5767%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    62.8

    Momentum Oscillators

    Stoch %K68.3
    Stoch %D74.0
    Williams %R-35.1
    ROC (10d)19.7%
    Momentum1.19
    CCI (20d)76.8
    MFI (14d)90.5

    Volatility Measures

    ATR (14d)$0.67(9.3%)
    StdDev (20d)0.90
    Hist Vol90.8%(High)

    Volume Flow

    VWAP$7.08
    OBV-311.5K
    AD Line-499.4K
    CMF (20d)-0.142

    Volume Metrics

    Avg Vol (20d)4.7K
    Vol Ratio0.2x(Low)
    VWMA (20d)$6.24

    Pivot Points

    R3$8.13
    R2$7.76
    R1$7.46
    Pivot Point$7.09
    S1$6.79
    S2$6.42
    S3$6.12

    Advanced Oscillators

    TSI21.86
    Ultimate Osc59.6
    KST254.81

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$137,756$0$0$0$0$0
    Cost of Revenue$1.13M$830,724$1.11M$845,174$1.07M$613,924$860,026$546,095$731,607$390,044N/A$119,146
    Gross Profit$-1,127,667$-830,724$-1,107,820$-845,174$-1,068,838$-613,924$-860,026$-546,095$-731,607$-390,044N/A$-119,146
    Operating Expenses$1.83M$1.56M$1.59M$1.68M$1.48M$1.34M$1.12M$1.07M$596,997$618,414$985,047$272,700
    R&D$1.44M$1.12M$1.11M$1.22M$802,991$575,016$630,302$723,487$237,395$277,582$550,340$27,936
    SG&A$376,306$424,937$454,786$452,097$634,381$736,471$483,598$326,483$349,888$336,940$504,776$237,752
    Operating Income$-2,953,890$-2,386,974$-2,695,490$-2,522,208$-2,548,045$-1,950,728$-1,983,317$-1,611,726$-1,328,604$-1,008,458$-985,047$-391,846
    Interest Income$1,840$13,716$133,737$59,185$76,557$94,307$152,041$-44,647$-29,782$0$0$0
    Interest Expense$0$0$64,751$0$0$0$0$44,647$29,782$0$71,250$0
    Income Before Tax$-2,878,614$-2,370,247$-2,760,241$-2,286,991$-2,360,286$-1,856,421$-1,838,118$-1,656,373$-1,358,386$-1,008,458$-1,056,297$-520,596
    Income Tax Expense$0$0$-105,205$0$0$0$-2,144$0$2,144$0$42,267$0
    Net Income$-2,878,614$-2,370,247$-2,655,036$-2,286,991$-2,360,286$-1,856,421$-1,835,974$-1,656,373$-1,360,530$-1,008,458$-1,098,564$-520,596
    EBITDA$-2,815,495$-2,321,808$-2,634,591$-2,287,628$-2,378,290$-1,893,680$-1,929,205$-1,557,301$-1,273,737$-958,839$-997,331$-520,596
    EBIT$-2,880,453$-2,383,963$-2,695,490$-2,346,176$-2,436,843$-1,950,728$-1,983,317$-1,611,726$-1,328,604$-1,008,458$-1,056,297$-520,596
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about EXOZ

    News

    EXOZ|eXoZymes Inc|Price:4.500|Chg%:-0.210

    eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme company that transforms sustainable feedstock into essential chemicals, medicines, and biofuels. The company uses AI to create advanced enzymes that operate in bioreactors, offering a sustainable alternative to traditional chemical production. The article outlines their company profile, executive team, and institutional shareholding data.

    TradingKey•7/27/26•
    Bullish

    EXOZ|eXoZymes Inc|Price:4.710|Chg%:+0.070

    This article provides an overview of eXoZymes Inc (EXOZ) stock, including its current price, market performance, key financial figures, and company information. It highlights the company's focus on AI-engineered enzymes for sustainable chemical production and lists major shareholders. The article also includes various technical indicators for stock analysis.

    TradingKey•7/26/26•
    Bearish

    If You Invested $1,000 in Invizyne Technologies Inc (IZTC)

    This article examines the historical investment performance of Invizyne Technologies Inc (IZTC), now known as eXoZymes Inc. (EXOZ), since its trading began in November 2024. It details how a $1,000 investment made then would be worth $1,908 today, representing a 91% return. The company, which specializes in cell-free, enzyme-based biomanufacturing, rebranded to eXoZymes Inc. to better reflect its AI-engineered enzyme technology.

    Stock Titan•7/6/26•
    Somewhat-Bullish

    Frequently Asked Questions About EXOZ

    Does EXOZ pay dividends?
    eXoZymes, Inc. (EXOZ) does not currently pay a regular dividend.
    What is EXOZ's market cap?
    eXoZymes, Inc. (EXOZ) has a market capitalization of $66.53M with a current stock price of $7.22.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In